vivax malaria vaccine (ChAd63 PvDBP/MVA PvDBP)
/ University of Oxford
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 12, 2024
VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines
(clinicaltrials.gov)
- P2 | N=16 | Completed | Sponsor: University of Oxford | Phase classification: P2a ➔ P2
Phase classification • Infectious Disease • Malaria
August 17, 2022
VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines
(clinicaltrials.gov)
- P2a | N=16 | Completed | Sponsor: University of Oxford | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Malaria
1 to 2
Of
2
Go to page
1